500 Is risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer beneficial with respect to distant disease free survival and overall survival?

Authors :: M. Menke-Pluimers
A. M. W. Van Den Ouweland
C.C.M. Bartels
Bernadette A M Heemskerk-Gerritsen
J.M. Collee
Agnes Jager
M.M.A. Tilanus-Linthorst
M.J. Hooning
Caroline Seynaeve
Source :: European Journal of Cancer Supplements. 8:206
Publication Year :: 2010
Publisher :: Elsevier BV, 2010.

Subjects :: Oncology
Cancer Research
medicine.medical_specialty
Risk reducing mastectomy
business.industry
Distant disease
medicine.disease
Brca1 2 mutation
Breast cancer
Internal medicine
medicine
Overall survival
business

Tools